| Autor: |
Weninger S; F-Prime Biomedical Research Initiative, Cambridge, MA, USA. Electronic address: sweninger@fbri.com., Carrillo MC; Medical & Scientific Relations Division, Alzheimer's Association, Chicago, IL, USA. Electronic address: mcarrillo@alz.org., Dunn B; Division of Neurology Products, U.S. Food and Drug Administration, Silver Spring, MD, USA., Aisen PS; University of Southern California Alzheimer's Therapeutic Research Institute, San Diego, CA, USA., Bateman RJ; Department of Neurology, Washington University, St Louis, MO, USA., Kotz JD; F-Prime Biomedical Research Initiative, Cambridge, MA, USA., Langbaum JB; Banner Alzheimer's Institute, Phoenix, AZ, USA., Mills SL; Department of Neurology, Washington University, St Louis, MO, USA., Reiman EM; Banner Alzheimer's Institute, Phoenix, AZ, USA., Sperling R; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Santacruz AM; Department of Neurology, Washington University, St Louis, MO, USA., Tariot PN; Banner Alzheimer's Institute, Phoenix, AZ, USA., Welsh-Bohmer KA; Departments of Neurology & Psychiatry, Duke University, Durham, NC, USA. |
